Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by mercedesmanon Apr 22, 2021 1:57pm
62 Views
Post# 33046097

RE:Float is Managed.

RE:Float is Managed. It seems to me that the float is not only being managed, it's tiny.

Volume is non existant.  The sp can be pushed around like a rag doll, for a few ten's of thousands of dollars.  On a $Billion opportunity no less

Unreal !

The cure?   Easy.   In no particular order:

1. PR, dissemination of news, medical & investor conference participation, analysts.

2. US Listing (or even announcementn of intent).  That's where the demand comes from  likely 50 to 100 times the appetite for Biotechs in the US vs. Canada.

3. FDA approvals, the first of 3 or more soon to be determined.

4. Broaden the number of shareholders and increase the size of the float.


I'm confident that ALL of the above is coming.  The managers aren't stupid.

The best part is there is a huge pending need - especially for Home Testing.  Read Vista's article link again... it's important.

https://www.yahoo.com/lifestyle/long-does-protection-covid-19-072750190.html

What product is positioned to tell people about their level of protection.  There will be rules of thumb about things like how long ago where you vaccinted, but EACH INDIVIDUAL WILL BE DIFFERENT.

SQI has the keys ! And the proven accuracy.


MM


<< Previous
Bullboard Posts
Next >>